Our results were consistent with previous researches that demonstrated that IFITM3 is overexpressed in many hunman malignancies, such as gastric cancer, colorectal cancer, oral squamous cell carcinoma, glioma, and breast cancer. This evidence concerns the gene IFITM3 and breast carcinoma.